Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development

Overview of attention for article published in Journal of neurology, neurosurgery and psychiatry, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 9 X users
patent: 8 patents

facebook: 2 Facebook pages

Readers on

mendeley: 151 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

THREE-DIMENSIONAL NEUROMUSCULAR JUNCTION ON CHIP

Application WO-2026150261-A1

World Intellectual Property Organisation (WIPO)

16 Jul 2026

AAV vectors with myelin protein zero promoter and uses thereof for treating SCHWANN cell-as…

Grant US-12582725-B2

United States of America

24 Mar 2026

Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease

Grant US-11939577-B2

United States of America

26 Mar 2024

TREATMENT OF CHARCOT-MARIE-TOOTH AXONAL TYPE 2D USING NT-3 GENE THERAPY

Application WO-2021211713-A1

World Intellectual Property Organisation (WIPO)

21 Oct 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.